Neuphoria Therapeutics Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Oct 513GPassive stake of 5% or more (13G), filed by AdvisorShares Trust
- Sep 1810-KAnnual report
- Jul 238-KMaterial agreement and Regulation FD disclosure1.015.017.019.01
- May 268-KOther events8.01
- May 1510-QQuarterly report
- Feb 1710-QQuarterly report
- Jan 78-KMaterial agreement and end of a material agreement1.011.029.01
- Dec 18, 20258-KListing notice or transfer3.01
- Dec 17, 20258-KShareholder vote5.07
- Nov 14, 2025424B5Prospectus for an offering
- Nov 14, 202510-QQuarterly report
- Oct 27, 20258-KMaterial agreement and bylaws or fiscal year changed1.013.035.038.019.01
- Oct 27, 2025424B5Prospectus for an offering
- Oct 20, 2025424B5Prospectus for an offering
- Oct 20, 20258-KOther events8.019.01
- Sep 29, 202510-KAnnual report
- Sep 23, 2025424B5Prospectus for an offering
- Sep 16, 20258-KListing notice or transfer3.019.01
- Jul 29, 2025424B5Prospectus for an offering
- Jul 18, 20258-KListing notice or transfer3.019.01
- May 20, 20258-KResults of operations2.029.01
- May 20, 202510-QQuarterly report
- Feb 14, 202510-QQuarterly report
- Feb 12, 2025424B5Prospectus for an offering
- Feb 4, 2025424B5Prospectus for an offering
- Jan 27, 2025S-3Shelf registration
- Jan 14, 20258-KOther events8.01
- Dec 23, 20248-KMaterial agreement and unregistered sale of shares1.013.013.023.035.015.025.035.058.019.01
- Dec 16, 20248-KOther events8.019.01
- Dec 12, 20248-KShareholder vote5.079.01
- Nov 21, 20248-KMaterial agreement1.019.01
- Nov 18, 2024S-3Shelf registration
- Nov 14, 202410-QQuarterly report
- Nov 8, 20248-KOther events8.019.01
- Oct 10, 20248-KOfficer or director change5.02